As shown in our study, using the SMN2-GFP reporter, the drug screening of a small pool library effectively identified candidate small molecules that can significantly increase the functional SMN, leading to the rescue of motor neuron degeneration in both the iPSC-based model of SMA and the SMNΔ7 mouse model. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.